CDC has issued a bulletin to its Health Alert Network (HAN) recommending that healthcare providers be watchful for unusual infectious diseases in patients and others who visit Puerto Rico, the Virgin Islands, and other Caribbean hurricane-ravaged areas between September 2017 and March 2018, including leptospirosis, dengue, hepatitis A, typhoid fever, vibriosis, Zika, chikungunya, and influenza. Also, visitors to flooded or contaminated areas of the Gulf and Atlantic Coasts could possibly return with necrotizing fasciitis, invasive fungi, Mycobacterium, Legionella, Pseudomonas, or other water-associated Gram-negative bacteria. The HAN, at https://emergency.cdc.gov/han/han00408.asp, provides specific recommendations and reporting requirements dealing with these possibilities.
The FDA has announced a Class 2 recall of about 165,000 Baxter Amia Automated Peritoneal Dialysis Sets with Cassette, REF 5C5479 because of a variety of technical issues. For lot numbers and other details see https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=158638 .
The numbers are not large, but deaths are being reported from West Nile Virus, with northern Los Angeles County reporting relatively more. The CDC web page on West Nile includes mosquito reduction methods and links to EPA reviews of insecticides; find it at https://www.cdc.gov/westnile/ . In most cases your state and county health departments also have their own pages on West Nile, with local instructions for reporting dead birds, which are markers for surveillance of the disease.
The FDA has announced a recall of three lots of Genentech Activase® (alteplase) 100mg vials, co-packaged with Sterile Water for Injection. The Sterile Water vial, packaged by Hospira, may be cracked or chipped at the neck and leaking. Lot numbers are 3128243, 3141239, and 3166728. For full details see https://www.fda.gov/Safety/Recalls/ucm574980.htm .
The FDA has published a safety communication on potassium-lowering drug Kayexalate and other brands of sodium polystyrene sulfonate because it has been found to bind to other oral medications, reducing their effectiveness. The FDA recommends separating the dosing of sodium polystyrene sulfonate from other orally administered medicines by at least 3 hours. They are updating sodium polystyrene sulfonate drug labels to include information about this dosing separation. For details see https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm574763.htm .
The FDA has announced a recall of alcohol pads and benzalkonium chloride antiseptic towelettes made by Foshan Flying Medical Products, due to the absence of sterility assurance, and risk of infection. For details see https://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm574576.htm .
The FDA has announced the recall of Vancomycin Hydrochloride for Injection, USP, 750 mg/vial (NDC 0409-6531-02) lot 632153A because of the possible presence of particulate matter (glass). For details see https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm574261.htm .